Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons > Carbocyclic ring bonded directly to the five-membered hetero ring > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/429
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons > Carbocyclic ring bonded directly to the five-membered hetero ring
Description: Subject matter wherein a carbocyclic ring is bonded directly to the five-membered hetero ring.

Patents under this class:

1 2 3 4 5

Patent Number	Title Of Patent	Date Issued
6605634	Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents	Aug. 12, 2003
6582457	Method of controlling body temperature while reducing shivering	Jun. 24, 2003
6576665	Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption	Jun. 10, 2003
6576632	Biaryl compounds useful as anticancer agents	Jun. 10, 2003
6548532	Indolecarboxylic compounds for treating seborrhea and complications thereof	Apr. 15, 2003
6548533	Ureido substituted pyrrolidines	Apr. 15, 2003
6541507	Indolecarboxylic compounds for inducing/stimulating hair growth and/or retarding hair loss	Apr. 1, 2003
6534546	Aniline derivatives possessing an inhibitory effect of nitric oxide synthase	Mar. 18, 2003
6531507	Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same	Mar. 11, 2003
6525085	Diaryl-enynes	Feb. 25, 2003
6525068	Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand	Feb. 25, 2003
6512002	Methods of treatment for premature ejaculation in a male	Jan. 28, 2003
6500856	Cyclic AMP-specific phosphodiesterase inhibitors	Dec. 31, 2002
6495543	Polycyclic azaindole compounds	Dec. 17, 2002
6476063	Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith	Nov. 5, 2002
6472433	Method for treatment of inflammation with R-NSAIDS	Oct. 29, 2002
6429213	Cyclic hydroxamic acids as metalloproteinase inhibitors	Aug. 6, 2002
6403611	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions	Jun. 11, 2002
6399619	Pyrrolidine modulators of chemokine receptor activity	Jun. 4, 2002
6391910	Kappa agonist compounds and pharmaceutical formulations thereof	May. 21, 2002
6380241	Treatment of diseases using endothelin antagonists	Apr. 30, 2002
6355669	Retinoic acid agonists as preventive and therapeutic agents for nephritis	Mar. 12, 2002
6350772	Treatment of auto-immune diseases by photochemotherapy	Feb. 26, 2002
6306421	Therapeutic inhibitor of vascular smooth muscle cells	Oct. 23, 2001
6284785	1-arenesulfonyl-2-aryl-pyrrolidine and pyridine derivatives	Sep. 4, 2001
6281228	Heterocyclic inhibitors of microsomal triglyceride transfer protein and method	Aug. 28, 2001
6274613	Cyclic imines as pesticides	Aug. 14, 2001
6265434	Pyrrolidine modulators of chemokine receptor activity	Jul. 24, 2001
6265433	LTA4 hydrolase inhibitors	Jul. 24, 2001
6258822	Urokinase inhibitors	Jul. 10, 2001
6184244	C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases	Feb. 6, 2001
RE37035	Phenylacetic acid benzylamides	Jan. 30, 2001
6174879	Aminocyclohexylesters and uses thereof	Jan. 16, 2001
6166013	Glucocortiocoid-selective agents	Dec. 26, 2000
6160018	Prophylactic composition and method for alzheimer's Disease	Dec. 12, 2000
6140360	Antifungal agent	Oct. 31, 2000
6110956	N-aryloxyethylamine derivatives for the treatment of depression	Aug. 29, 2000
6096779	Amorphous piretanide, piretanide polymorphs, process for their preparation and their use	Aug. 1, 2000
6077863	2-aryl-4-halo-5-(trifluoromethyl)pyrrole-3-carbonitriles for the protection of wood, wood products and wooden structures from insect attack	Jun. 20, 2000
6074659	Therapeutic inhibitor of vascular smooth muscle cells	Jun. 13, 2000
6057358	Amine derivatives, processes for producing them and a use of them as antiarrhythmic drugs	May. 2, 2000
6054445	Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritis therewith	Apr. 25, 2000
6034109	Method for protection of heart by limiting metabolic and ionic abnormalities developed during ischemia following ischemia or resulting from ischemia	Mar. 7, 2000
6025395	Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders	Feb. 15, 2000
5998459	Pyrrole derivatives and medicinal composition	Dec. 7, 1999
5985864	Polymorphs of donepezil hydrochloride and process for production	Nov. 16, 1999
5981513	Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith	Nov. 9, 1999
5968968	Diphenyl-cyclopropenes as selective K-agonists	Oct. 19, 1999
5965577	Heterocyclic inhibitors of microsomal triglyceride transfer protein and method	Oct. 12, 1999
5945443	Kappa agonist compounds and pharmaceutical formulations thereof	Aug. 31, 1999